Language:
English
Make a difference for people living with osteoarthritis
We need your email to keep you updated on the status of your application
The study will evaluate a potential osteoarthritis treatment that is being developed to potentially reduce pain of the affected knee
The treatment is administered by one injection into the affected knee
During a period of 20 weeks participants will visit a clinic 7 times
During the study, the participants will score their pain level on a daily basis, via a tablet that will be handed out at the second visit in the clinic
The study is sponsored by Biosplice Therapeutics, and is conducted by NBCD in collaboration with Studies&Me
The study has been approved by the local institutional review board, and is registered on clinicaltrials.gov


